NDC 70121-2484 – Boruzu

Bortezomib 3.5 mg/1.4mL · Injection · Intravenous, Subcutaneous

Human Prescription Drug

Product NDC70121-2484

Product details

Brand name
Boruzu
Generic name
Bortezomib
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Injection
Route
Intravenous, Subcutaneous
Marketing category
NDA · NDA212782
Marketed since
September 27, 2024
Listing expires
December 31, 2026
Pharmacologic class
Proteasome Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Boruzu →

Package NDC codes (1)

Package NDCDescriptionSince
70121-2484-11 VIAL, SINGLE-DOSE in 1 CARTON (70121-2484-1) / 1.4 mL in 1 VIAL, SINGLE-DOSESep 27, 2024